The Erasmus Immunology Publications

PUBLICATIONS 2019
Stavast CJ, Erkeland SJ. The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation. Cells. 2019 Nov 19;8(11). PMID: 31752361
Ghanbari M, Munshi ST, Ma B, Lendemeijer B, Bansal S, Erkeland SJ, et al. A functional variant in the miR-142 promoter modulating its expression and conferring risk of Alzheimer disease. Hum Mutat. 2019 Nov;40(11):2131-2145. PMID: 31322790
Zhao M, De Crignis E, Rokx C, Verbon A, van Gelder T, Mahmoudi T, et al. T cell toxicity of HIV latency reversing agents. Pharmacol Res. 2019;139:524-34.
Tirosh I, Yamazaki Y, Frugoni F, Ververs FA, Allenspach EJ, Zhang Y, et al. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype. J Allergy Clin Immunol. 2019;143(2):726-35.
Ten Berge JC, Fazil Z, van den Born I, Wolfs RCW, Schreurs MWJ, Dik WA, et al. Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract. Acta Ophthalmol. 2019;97(2):185-92.
Smolders J, Jacobs BC, Tio-Gillen AP, Nijhuis F, Verrips A. Mycoplasma Pneumoniae and Antibodies against Galactocerebroside in a 9-Year-Old Boy with Encephalitis. Neuropediatrics. 2019;50(1):54-6.
Schutz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, et al. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group. J Clin Immunol. 2019;39(1):45-54.
Meyer Sauteur PM, de Bruijn A, Graca C, Tio-Gillen AP, Estevao SC, Hoogenboezem T, et al. Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae. Infect Immun. 2019;87(2).
Meshaal SS, El Hawary RE, Abd Elaziz DS, Eldash A, Alkady R, Lotfy S, et al. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population. Clin Exp Immunol. 2019;195(2):202-12.
Langerak AW, Ritgen M, Goede V, Robrecht S, Bahlo J, Fischer K, et al. Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood. 2019;133(5):494-7.
Kater AP, Seymour JF, Hillmen P, Eichhorst B, Langerak AW, Owen C, et al. Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study. J Clin Oncol. 2019;37(4):269-77.
Groen-Hakan F, Eurelings L, van Laar J, Rothova A. Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):175-80.
Detiger SE, Karim AF, van Laar JAM, Paridaens D, Verdijk RM. The histological absence of IgG4 positive plasma cells in juvenile xanthogranuloma; comments on ‘Systemic juvenile xanthogranuloma: a case report and brief review’. Clin Exp Dermatol. 2019;44(1):91-2.
Brem MD, Jacobs BC, van Rijs W, Fokkink WJR, Tio-Gillen AP, Walgaard C, et al. IVIg-induced plasmablasts in patients with Guillain-Barre syndrome. Ann Clin Transl Neurol. 2019;6(1):129-43.
Al-Hakem H, Sindrup SH, Andersen H, de la Cour CD, Lassen LL, van den Berg B, et al. Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J Neurol. 2019;266(2):440-9.
Zhu C, Mustafa DAM, Krebber MM, Chrifi I, Leenen PJM, Duncker DJ, et al. Comparative proteomic analysis of cat eye syndrome critical region protein 1- function in tumor-associated macrophages and immune response regulation of glial tumors. Oncotarget. 2018;9(71):33500-14.
PUBLICATIONS 2018
Zeijlemaker W, Grob T, Meijer R, Hanekamp D, Kelder A, Carbaat-Ham JC, et al. CD34(+)CD38(-) leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia. 2018.
Yeh EA, Hintzen RQ. Specific myelopathy diagnoses using advancing diagnostics: Idiopathic no more. Neurology. 2018;90(2):51-2.
Wong YYM, van der Vuurst de Vries RM, van Pelt ED, Ketelslegers IA, Melief MJ, Wierenga AF, et al. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes. Mult Scler. 2018;24(13):1715-24.
Wijntjes J, Bechakra M, Schreurs MWJ, Jongen JLM, Koppenaal A, Titulaer MJ. Pruritus in anti-DPPX encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):e455.
Wijdeven RH, van Luijn MM, Wierenga-Wolf AF, Akkermans JJ, van den Elsen PJ, Hintzen RQ, et al. Chemical and genetic control of IFNgamma-induced MHCII expression. EMBO Rep. 2018;19(9).
Wentink MWJ, van Zelm MC, van Dongen JJM, Warnatz K, van der Burg M. Deficiencies in the CD19 complex. Clin Immunol. 2018;195:82-7.
Wentink MWJ, Mueller YM, Dalm V, Driessen GJ, van Hagen PM, van Montfrans JM, et al. Exhaustion of the CD8(+) T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta. Front Immunol. 2018;9(MAR):446.
Wentink M. Connecting B cell differentiation pathways and antibody deficiencies [Ph.D. thesis]: Erasmus University Rotterdam; 2018.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA, et al. Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial. J Peripher Nerv Syst. 2018;23(4):210-5.
Wahadat MJ, Bodewes ILA, Maria NI, van Helden-Meeuwsen CG, van Dijk-Hummelman A, Steenwijk EC, et al. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? Arthritis Res Ther. 2018;20(1):4.
Villarese P, Lours C, Trinquand A, Le Noir S, Belhocine M, Lhermitte L, et al. TCRalpha rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome. Leukemia. 2018;32(1):61-71.
Vermeulen R, Saberi Hosnijeh F, Bodinier B, Portengen L, Liquet B, Garrido-Manriquez J, et al. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses. Int J Cancer. 2018;143(6):1335-47.
Verhoekx JSN, Karim AF, van Laar JAM, Verdijk RM, Paridaens D. The tarsal plate manifestation of IgG4-related disease. Int Ophthalmol. 2018.
Vergaelen E, Schiweck C, Van Steeland K, Counotte J, Veling W, Swillen A, et al. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis? Brain Behav Immun. 2018;70:88-95.
van Schouwenburg PA, H IJ, Pico-Knijnenburg I, Dalm V, van Hagen PM, van Zessen D, et al. Identification of CVID Patients With Defects in Immune Repertoire Formation or Specification. Front Immunol. 2018;9(NOV):2545.
van Rees GF, Lago SG, Cox DA, Tomasik J, Rustogi N, Weigelt K, et al. Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients. Brain Behav Immun. 2018;67:364-73.
Van Nieuwenhove E, Garcia-Perez JE, Helsen C, Rodriguez PD, van Schouwenburg PA, Dooley J, et al. A kindred with mutant IKAROS and autoimmunity. J Allergy Clin Immunol. 2018;142(2):699-702 e12.
van Langelaar J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, Spilt IM, Siepman TA, et al. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain. 2018;141(5):1334-49.
van Laar JAM. Can epidemiological studies uncover the origin of Behcet’s disease? Rheumatology (Oxford). 2018;57(1):3-4.
van Gammeren AJ, van Rijckevorsel M, Bras AE, Brandt-Hagens C, Te Marvelde JG, de Visser C, et al. Usability of femoral head bone marrow to verify reference ranges for the assessment of myelodysplasia by flow cytometry. Int J Lab Hematol. 2018;40(6):726-33.
van Eijk JJJ, Cintas P, Jacobs BC, Kamar N, Dalton HR. Reply to: “Association of hepatitis E virus infection and myasthenia gravis: A pilot study”. J Hepatol. 2018;68(6):1321-2.
van der Vuurst de Vries RM, Wong YYM, Mescheriakova JY, van Pelt ED, Runia TF, Jafari N, et al. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. Mult Scler. 2018:1352458518775303.
van der Straten L, Dinmohamed AG, Westerweel PE, Langerak AW, Riedl J, Doorduijn JK, et al. Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy. Leuk Lymphoma. 2018:1-5.
van der Spek AH, Surovtseva OV, Jim KK, van Oudenaren A, Brouwer MC, Vandenbroucke-Grauls C, et al. Regulation of Intracellular Triiodothyronine Is Essential for Optimal Macrophage Function. Endocrinology. 2018;159(5):2241-52.
van der Pol P, Bakker-Jonges LE, Kuijpers J, Schreurs MWJ. Analytical and clinical comparison of two fully automated immunoassay systems for the detection of autoantibodies to extractable nuclear antigens. Clin Chim Acta. 2018;476:154-9.
van der Meulen M, Bromberg JEC, Lam KH, Dammers R, Langerak AW, Doorduijn JK, et al. Flow cytometry shows added value in diagnosing lymphoma in brain biopsies. Cytometry B Clin Cytom. 2018;94(6):928-34.
van der Heiden M, de Rond LGH, van Zelm MC, Berbers GAM, Boots AMH, Buisman AM. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults. Front Immunol. 2018;9:46.
van den Bossche WBL, Rykov K, Teodosio C, Ten Have B, Knobben BAS, Sietsma MS, et al. Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage. Clin Immunol. 2018;197:224-30.
van den Bossche WBL, Kleijn A, Teunissen CE, Voerman JSA, Teodosio C, Noske DP, et al. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment. Neuro Oncol. 2018;20(11):1494-504.
van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH, Jacobs BC. Clinical outcome of Guillain-Barre syndrome after prolonged mechanical ventilation. J Neurol Neurosurg Psychiatry. 2018;89(9):949-54.
van de Bovenkamp FS, Derksen NIL, Ooijevaar-de Heer P, van Schie KA, Kruithof S, Berkowska MA, et al. Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region. Proc Natl Acad Sci U S A. 2018;115(8):1901-6.
van Beek AA, Fransen F, Meijer B, de Vos P, Knol EF, Savelkoul HFJ. Aged mice display altered numbers and phenotype of basophils, and bone marrow-derived basophil activation, with a limited role for aging-associated microbiota. Immun Ageing. 2018;15:32.
Unger S, Seidl M, van Schouwenburg P, Rakhmanov M, Bulashevska A, Frede N, et al. The TH1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J Allergy Clin Immunol. 2018;141(2):730-40.
Timmermans M. Immunopathogenesis of Granulomas in Chronic Inflammatory Diseases : Relevance to diagnostics, biomarkers and treatment [Ph.D. thesis]: Erasmus University Rotterdam; 2018.
Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, et al. No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. Front Immunol. 2018;9:1506.
Ten Berge JC, Schreurs MWJ, van Daele PLA, Rothova A. Autoimmunity in uveitis. Acta Ophthalmol. 2018;96(5):481-5.
Ten Berge JC, Schreurs MW, van Rosmalen J, Rothova A. Autoantibody profiling in intraocular fluid of patients with uveitis. Exp Eye Res. 2018;176:141-6.
Ten Berge JC, Groen-Hakan F, Rothova A, Schreurs MWJ. Antinuclear antibody profiling in uveitis. Acta Ophthalmol. 2018;96(5):e660-e1.
Ten Berge J, van Dijk EHC, Schreurs MWJ, Vermeer J, Boon CJF, Rothova A. Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications. Acta Ophthalmol. 2018;96(1):56-62.
Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MWJ, et al. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. J Peripher Nerv Syst. 2018;23(4):227-34.
Stelekati E, Chen Z, Manne S, Kurachi M, Ali MA, Lewy K, et al. Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155. Cell Rep. 2018;23(7):2142-56.
Stavast CJ, Leenen PJM, Erkeland SJ. The interplay between critical transcription factors and microRNAs in the control of normal and malignant myelopoiesis. Cancer Lett. 2018;427:28-37.
Sonderen AV, Arends S, Tavy DLJ, Bastiaansen AEM, Bruijn M, Schreurs MWJ, et al. Predictive value of electroencephalography in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2018;89(10):1101-6.
Snijders G, Titulaer MJ, Bergink V, Bastiaansen AE, Schreurs MWJ, Ophoff RA, et al. No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder. Psychiatry Res. 2018;259:460-2.
Smith V, Scire CA, Talarico R, Airo P, Alexander T, Allanore Y, et al. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000782.
Shariatzadeh M, Brandt MM, Cheng C, Ten Berge JC, Rothova A, Leenen PJM, et al. Three-dimensional tubule formation assay as therapeutic screening model for ocular microvascular disorders. Eye (Lond). 2018;32(8):1380-6.
Sedek L, Theunissen P, Sobral da Costa E, van der Sluijs-Gelling A, Mejstrikova E, Gaipa G, et al. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia. J Immunol Methods. 2018.
Schreurs MWJ, De Vries A. Immunoassays voor het meten van serumconcentraties biologics ean anti-biologic antilichamen bij patiënten. . Bijblijven. 2018;34:179-86.
Schoenaker MHD, Henriet SS, Zonderland J, van Deuren M, Pan-Hammarstrom Q, Posthumus-van Sluijs SJ, et al. Immunodeficiency in Bloom’s Syndrome. J Clin Immunol. 2018;38(1):35-44.
Saberi Hosnijeh F, Kavousi M, Boer CG, Uitterlinden AG, Hofman A, Reijman M, et al. Development of a prediction model for future risk of radiographic hip osteoarthritis. Osteoarthritis Cartilage. 2018;26(4):540-6.
Romao VC, Talarico R, Scire CA, Vieira A, Alexander T, Baldini C, et al. Sjogren’s syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000789.
Rijvers L, Melief MJ, van der Vuurst de Vries RM, Stephant M, van Langelaar J, Wierenga-Wolf AF, et al. The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis. Eur J Immunol. 2018;48(11):1861-71.
Razawy W, van Driel M, Lubberts E. The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling. Eur J Immunol. 2018;48(2):220-9.
Ponsford MJ, Klocperk A, Pulvirenti F, Dalm V, Milota T, Cinetto F, et al. Hyper-IgE in the allergy clinic–when is it primary immunodeficiency? Allergy. 2018;73(11):2122-36.
Pfajfer L, Mair NK, Jimenez-Heredia R, Genel F, Gulez N, Ardeniz O, et al. Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity. J Allergy Clin Immunol. 2018;142(5):1589-604 e11.
Palstra RJ, de Crignis E, Roling MD, van Staveren T, Kan TW, van Ijcken W, et al. Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1. Sci Adv. 2018;4(2):e1701729.
Pal Singh S, de Bruijn MJW, de Almeida MP, Meijers RWJ, Nitschke L, Langerak AW, et al. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency. Front Immunol. 2018;9(SEP):1996.
Pal Singh S, Dammeijer F, Hendriks RW. Role of Bruton’s tyrosine kinase in B cells and malignancies. Mol Cancer. 2018;17(1):57.
Nechvatalova J, Bartol SJW, Chovancova Z, Boon L, Vlkova M, van Zelm MC. Absence of Surface IgD Does Not Impair Naive B Cell Homeostasis or Memory B Cell Formation in IGHD Haploinsufficient Humans. J Immunol. 2018;201(7):1928-35.
Mulders-Manders CM, Kanters TA, van Daele PLA, Hoppenreijs E, Legger GE, van Laar JAM, et al. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study. Orphanet J Rare Dis. 2018;13(1):59.
Mulder VC, Bastiaans J, van Leuven CJM, van Meurs JC, Kluft C. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment. Ophthalmologica. 2018;240(1):23-8.
Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gur-Demirel Y, et al. Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners. Lung. 2018;196(5):569-75.
Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Drenthen J, Unger WWJ, Jacobs E, et al. Intrathecal antibody responses to GalC in Guillain-Barre syndrome triggered by Mycoplasma pneumoniae. J Neuroimmunol. 2018;314:13-6.
Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, de Wit MY, Unger WWJ, Berger C, et al. Antibody responses to GalC in severe and complicated childhood Guillain-Barre syndrome. J Peripher Nerv Syst. 2018;23(1):67-9.
Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville A, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273-84.
Meesilpavikkai K, Dik WA, Schrijver B, Nagtzaam NMA, Posthumus-van Sluijs SJ, van Hagen PM, et al. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1). J Allergy Clin Immunol. 2018;142(1):328-30 e2.
Matarraz S, Leoz P, Fernandez C, Colado E, Chillon MC, Vidriales MB, et al. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy. Mod Pathol. 2018;31(8):1318-31.
Liu C, Dalm V, van Hagen PM, Croon-de Boer F, Paridaens D. Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma. Orbit. 2018;37(4):299-302.
Lhermitte L, Mejstrikova E, van der Sluijs-Gelling AJ, Grigore GE, Sedek L, Bras AE, et al. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia. Leukemia. 2018;32(4):874-81.
Leonhard SE, Munts AG, van der Eijk AA, Jacobs BC. Acute-onset chronic inflammatory demyelinating polyneuropathy after Zika virus infection. J Neurol Neurosurg Psychiatry. 2018;89(10):1118-9.
Leonhard SE, Lant S, Jacobs BC, Wilder-Smith A, Ferreira MLB, Solomon T, et al. Zika virus infection in the returning traveller: what every neurologist should know. Pract Neurol. 2018;18(4):271-7.
Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, et al. IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation. J Clin Immunol. 2018;38(2):185-92.
Langerak AW, Assmann J. Large granular lymphocyte cells and immune dysregulation diseases – the chicken or the egg? Haematologica. 2018;103(2):193-4.
Laksono BM, Grosserichter-Wagener C, de Vries RD, Langeveld SAG, Brem MD, van Dongen JJM, et al. In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells. J Virol. 2018;92(8).
Laksono BM, de Vries RD, Verburgh RJ, Visser EG, de Jong A, Fraaij PLA, et al. Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nat Commun. 2018;9(1):4944.
La Distia Nora R, Walburg KV, van Hagen PM, Swagemakers SMA, van der Spek PJ, Quinten E, et al. Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon Signaling. Invest Ophthalmol Vis Sci. 2018;59(3):1384-95.
La Distia Nora R, Ten Berge JC, Rothova A, Schreurs MW. Antinuclear and antiretinal antibodies in uveitis associated with active and latent tuberculosis. Acta Ophthalmol. 2018;96(5):e659-e60.
La Distia Nora R, Sitompul R, Bakker M, Versnel MA, Swagemakers SMA, van der Spek PJ, et al. Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis? PLoS One. 2018;13(10):e0206073.
La Distia Nora R. Mycobacterium Tuberculosis-Associated Uveitis: Infection and Autoimmunity [Ph.D. thesis]: Erasmus University Rotterdam; 2018.
Kuitwaard K, Fokkink WR, Brusse E, Vrancken A, Eftimov F, Notermans NC, et al. Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study). J Peripher Nerv Syst. 2018;23(1):5-10.
Kriek N, Schreurs MWJ, Groeneweg JG, Dik WA, Tjiang GCH, Gultuna I, et al. Spinal Cord Stimulation in Patients With Complex Regional Pain Syndrome: A Possible Target for Immunomodulation? Neuromodulation. 2018;21(1):77-86.
Karim AF, Hermans MA, Verdijk RM, Van Hagen PM, Van Laar JA. IgG4-gerelateerde ziekte: huidige stand van zaken. . Nederlands Tijdschrift voor Allergie, Astma en Klinische Immunologie. 2018(18):3-9.
Karim AF, Heeringa JJ, van Laar JAM, Verdijk RM, Dik WA, Paridaens AD, et al. Reply. J Allergy Clin Immunol. 2018;141(5):1958-60 e4.
Karim AF, Eurelings LEM, van Hagen PM, van Laar JAM. Implications of elevated C-reactive protein and serum amyloid A levels in IgG4-related disease: comment on the article by Perugino et al. Arthritis Rheumatol. 2018;70(2):317-8.
Karim AF, Eurelings LEM, Bansie RD, van Hagen PM, van Laar JAM, Dik WA. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease. Mediators Inflamm. 2018;2018:6103064.
Kallemeijn MJ, Kavelaars FG, van der Klift MY, Wolvers-Tettero ILM, Valk PJM, van Dongen JJM, et al. Next-Generation Sequencing Analysis of the Human TCRgammadelta+ T-Cell Repertoire Reveals Shifts in Vgamma- and Vdelta-Usage in Memory Populations upon Aging. Front Immunol. 2018;9(MAR):448.
Kallemeijn M. Normal and Aberrant TCRγδ+ T Cells and T Cell Large Granular Lymphocyte Leukemia [Ph.D. thesis]: Erasmus University Rotterdam; 2018.
Jansen M, van Zelm M, Groeneweg M, Jaddoe V, Dik W, Schreurs M, et al. The identification of celiac disease in asymptomatic children: the Generation R Study. J Gastroenterol. 2018;53(3):377-86.
Islam B, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, et al. Small volume plasma exchange for Guillain-Barre syndrome in resource-limited settings: a phase II safety and feasibility study. BMJ Open. 2018;8(8):e022862.
Islam B, Islam Z, GeurtsvanKessel CH, Jahan I, Endtz HP, Mohammad QD, et al. Guillain-Barre syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis. 2018;37(3):511-8.
Indhirajanti S, van Daele PLA, Bos S, Mulder MT, Bot I, Roeters van Lennep JE. Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels. Atherosclerosis. 2018;268:152-6.
Hoogeveen PG, de Bie M, Noordijk R, Sonneveld E, Koning-Goedheer A, Beverloo HB, et al. Pitfalls in short-tandem repeat analysis as quality control for sample mix-up of pediatric acute lymphoblastic leukemia patients. Leuk Lymphoma. 2018;59(6):1508-10.
Hermans MAW, Schrijver B, van Holten-Neelen C, Gerth van Wijk R, van Hagen PM, van Daele PLA, et al. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release. Clin Exp Allergy. 2018;48(11):1412-20.
Heeringa JJ, Rijvers L, Arends NJ, Driessen GJ, Pasmans SG, van Dongen JJM, et al. IgE-expressing memory B cells and plasmablasts are increased in blood of children with asthma, food allergy, and atopic dermatitis. Allergy. 2018;73(6):1331-6.
Heeringa JJ, Karim AF, van Laar JAM, Verdijk RM, Paridaens D, van Hagen PM, et al. Expansion of blood IgG4(+) B, TH2, and regulatory T cells in patients with IgG4-related disease. J Allergy Clin Immunol. 2018;141(5):1831-43 e10.
Heeringa JJ, Fieten KB, Bruins FM, van Hoffen E, Knol EF, Pasmans S, et al. Treatment for moderate to severe atopic dermatitis in alpine and moderate maritime climates differentially affects helper T cells and memory B cells in children. Clin Exp Allergy. 2018;48(6):679-90.
Heeringa J. The B-cell side of Allergy and Chronic Inflammatory Disease: Studies on the source of IgE and IgG4 [Ph.D. thesis]: Erasmus University Rotterdam; 2018.
Hanekamp D, Denys B, Kaspers GJL, Te Marvelde JG, Schuurhuis GJ, De Haas V, et al. Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients. Br J Haematol. 2018;183(3):512-6.
Hancock AS, Stairiker CJ, Boesteanu AC, Monzon-Casanova E, Lukasiak S, Mueller YM, et al. Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation. J Virol. 2018;92(21).
Haarman BCM, Burger H, Drexhage HA, Nolen WA, Riemersma-Van der Lek RF. [The dysregulated brain – Consequences of spatial and temporal brain complexity for bipolar disorder pathophysiology and diagnosis]
Het ontregelde brein; consequenties van ruimtelijke en temporele complexiteit van het brein voor pathofysiologie en diagnostiek van de bipolaire stoornis. Tijdschr Psychiatr. 2018;60(2):105-13.
Groen-Hakan F, Eurelings L, Rothova A, van Laar J. Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis. Br J Ophthalmol. 2018.
Ghanbari M, Peters MJ, de Vries PS, Boer CG, van Rooij JGJ, Lee YC, et al. A systematic analysis highlights multiple long non-coding RNAs associated with cardiometabolic disorders. J Hum Genet. 2018;63(4):431-46.
GeurtsvanKessel CH, Islam Z, Jacobs BC, Endtz HP. Reply to: Comment on: Zika virus and Guillain-Barre syndrome in Bangladesh. Ann Clin Transl Neurol. 2018;5(9):1140-1.
GeurtsvanKessel CH, Islam Z, Islam MB, Kamga S, Papri N, van de Vijver D, et al. Zika virus and Guillain-Barre syndrome in Bangladesh. Ann Clin Transl Neurol. 2018;5(5):606-15.
Flasinski M, Scheibke K, Zimmermann M, Creutzig U, Reinhardt K, Verwer F, et al. Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study. Blood Adv. 2018;2(13):1532-40.
Fazil Z, Ten Berge JC, Langerak AW, Rothova A, Dik WA. An Intraocular Inflammatory Profile of Rubella Associated Uveitis. Ocul Immunol Inflamm. 2018:1-6.
Falkenburg WJJ, von Richthofen HJ, Koers J, Weykamp C, Schreurs MWJ, Bakker-Jonges LE, et al. Clinically relevant discrepancies between different rheumatoid factor assays. Clin Chem Lab Med. 2018;56(10):1749-58.
Esenboga S, Cagdas D, Ozgur TT, Gur Cetinkaya P, Turkdemir LM, Sanal O, et al. Clinical and genetic features of the patients with X-Linked agammaglobulinemia from Turkey: Single-centre experience. Scand J Immunol. 2018;87(3).
Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain-Barre syndrome. Brain. 2018;141(10):2866-77.
Doets AY, Jacobs BC, van Doorn PA. Advances in management of Guillain-Barre syndrome. Curr Opin Neurol. 2018;31(5):541-50.
Dimier N, Delmar P, Ward C, Morariu-Zamfir R, Fingerle-Rowson G, Bahlo J, et al. A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. Blood. 2018;131(9):955-62.
de Wit J, Brada RJK, van Veldhuizen J, Dalm V, Pasmans S. Skin disorders are prominent features in primary immunodeficiency diseases: A systematic overview of current data. Allergy. 2018.
de Goeje PL, Klaver Y, Kaijen-Lambers MEH, Langerak AW, Vroman H, Kunert A, et al. Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS. Front Immunol. 2018;9(SEP):2034.
de Bruijn M, Aarsen FK, van Oosterhout MP, van der Knoop MM, Catsman-Berrevoets CE, Schreurs MWJ, et al. Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis. Neurology. 2018;90(22):e1997-e2005.
Dankers W, Gonzalez-Leal C, Davelaar N, Asmawidjaja PS, Mus AMC, Hazes JMW, et al. 1,25(OH)2D3 and dexamethasone additively suppress synovial fibroblast activation by CCR6(+) T helper memory cells and enhance the effect of tumor necrosis factor alpha blockade. Arthritis Res Ther. 2018;20(1):212.
Damoiseaux J, Schreurs MWJ, al. e. International Consensus on ANA Patterns (ICAP): inbedding in het Nederlandse taalgebied. . Laboratoriumgeneeskunde. 2018;3:17-26.
Counotte J, Drexhage HA, Wijkhuijs JM, Pot-Kolder R, Bergink V, Hoek HW, et al. Th17/T regulator cell balance and NK cell numbers in relation to psychosis liability and social stress reactivity. Brain Behav Immun. 2018;69:408-17.
Cazzaniga G, De Lorenzo P, Alten J, Rottgers S, Hancock J, Saha V, et al. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies. Haematologica. 2018;103(1):107-15.
Bunschoten C, Eftimov F, van der Pol WL, Jacobs BC, Consortium I. International chronic inflammatory demyelinating polyneuropathy outcome study (ICOS): Protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome. J Peripher Nerv Syst. 2018.
Buizert A, Verboon JC, Wirtz PW, Koopman JP, van Roosmalen RM, Jacobs BC, et al. [Bell’s palsy: different doctor, different care?]
Bellse parese: andere dokter, andere zorg? Ned Tijdschr Geneeskd. 2018;162(35).
Bras AE, de Haas V, van Stigt A, Jongen-Lavrencic M, Beverloo HB, Te Marvelde JG, et al. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping. Cytometry B Clin Cytom. 2018.
Bras AE, Beishuizen A, Langerak AW, Jongen-Lavrencic M, Te Marvelde JG, van den Heuvel-Eibrink MM, et al. CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy. Br J Haematol. 2018;180(2):292-6.
Bouwens van der Vlis TAM, Kros JM, Mustafa DAM, van Wijck RTA, Ackermans L, van Hagen PM, et al. The complement system in glioblastoma multiforme. Acta Neuropathol Commun. 2018;6(1):91.
Boeddha NP, Kerklaan D, Dunbar A, van Puffelen E, Nagtzaam NMA, Vanhorebeek I, et al. HLA-DR Expression on Monocyte Subsets in Critically Ill Children. Pediatr Infect Dis J. 2018;37(10):1034-40.
Bodewes ILA, Versnel MA. Interferon activation in primary Sjogren’s syndrome: recent insights and future perspective as novel treatment target. Expert Rev Clin Immunol. 2018;14(10):817-29.
Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm V, et al. TBK1: A key regulator and potential treatment target for interferon positive Sjogren’s syndrome, systemic lupus erythematosus and systemic sclerosis. J Autoimmun. 2018;91:97-102.
Bodewes ILA, Al-Ali S, van Helden-Meeuwsen CG, Maria NI, Tarn J, Lendrem DW, et al. Systemic interferon type I and type II signatures in primary Sjogren’s syndrome reveal differences in biological disease activity. Rheumatology (Oxford). 2018;57(5):921-30.
Blanco E, Perez-Andres M, Arriba-Mendez S, Contreras-Sanfeliciano T, Criado I, Pelak O, et al. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J Allergy Clin Immunol. 2018;141(6):2208-19 e16.
Bjorkman A, Du L, van der Burg M, Cormier-Daire V, Borck G, Pie J, et al. Reduced immunoglobulin gene diversity in patients with Cornelia de Lange syndrome. J Allergy Clin Immunol. 2018;141(1):408-11 e8.
Berger E, Delpierre C, Hosnijeh FS, Kelly-Irving M, Portengen L, Bergdahl IA, et al. Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts. Sci Rep. 2018;8(1):10805.
Becking K, Haarman BCM, Grosse L, Nolen WA, Claes S, Arolt V, et al. The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder. J Neuroimmunol. 2018;319:28-36.
Bastiaans J, Mulder VC, van Meurs JC, Smits-Te Nijenhuis M, van Holten-Neelen C, van Hagen PM, et al. Dabigatran inhibits intravitreal thrombin activity. Acta Ophthalmol. 2018;96(5):452-8.
Basak EA, Wijkhuijs AJM, Mathijssen RHJ, Koolen SLW, Schreurs MWJ. Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum Concentrations. Ther Drug Monit. 2018;40(5):596-601.
Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, et al. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica. 2018;103(4):e158-e61.
Agathangelidis A, Sutton LA, Hadzidimitriou A, Tresoldi C, Langerak AW, Belessi C, et al. Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation. J Vis Exp. 2018;2018(141).
PUBLICATIONS 2017
Zoutman WH, Nell RJ, Versluis M, van Steenderen D, Lalai RN, Out-Luiting JJ, et al. Accurate Quantification of T Cells by Measuring Loss of Germline T-Cell Receptor Loci with Generic Single Duplex Droplet Digital PCR Assays. J Mol Diagn. 2017;19(2):236-43.
Zhu C, Mustafa D, Zheng PP, van der Weiden M, Sacchetti A, Brandt M, et al. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression. Neuro Oncol. 2017;19(5):648-59.
Zhu C, Chrifi I, Mustafa D, van der Weiden M, Leenen PJM, Duncker DJ, et al. CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma. Oncogene. 2017;36(38):5356-68.
Zhou X, Huang F, Xu L, Lin Z, de Vrij FMS, Ayo-Martin AC, et al. Hepatitis E Virus Infects Neurons and Brains. J Infect Dis. 2017;215(8):1197-206.
Young E, Noerenberg D, Mansouri L, Ljungstrom V, Frick M, Sutton LA, et al. EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. Leukemia. 2017;31(7):1547-54.
Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton LA, Minga E, et al. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes. Clin Cancer Res. 2017;23(17):5292-301.
Wren D, Walker BA, Bruggemann M, Catherwood MA, Pott C, Stamatopoulos K, et al. Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing. Haematologica. 2017;102(2):e57-e60.
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: surveillance and cost of treatment strategies – Authors’ reply. Lancet. 2017;389(10066):253-4.
Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, et al. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group. Haematologica. 2017;102(2):308-19.
Wentink M, Dalm V, Lankester AC, van Schouwenburg PA, Scholvinck L, Kalina T, et al. Genetic defects in PI3Kdelta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86.
Walgaard C, Lingsma HF, van Doorn PA, van der Jagt M, Steyerberg EW, Jacobs BC. Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barre Syndrome. Neurocrit Care. 2017;26(1):6-13.
Waanders E, Scheijen B, Jongmans MC, Venselaar H, van Reijmersdal SV, van Dijk AH, et al. Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences. Leukemia. 2017;31(4):821-8.
Vogels RJ, Koenders MA, van Rossum EF, Spijker AT, Drexhage HA. T Cell Deficits and Overexpression of Hepatocyte Growth Factor in Anti-inflammatory Circulating Monocytes of Middle-Aged Patients with Bipolar Disorder Characterized by a High Prevalence of the Metabolic Syndrome. Front Psychiatry. 2017;8(MAR):34.
Verboon C, van Doorn PA, Jacobs BC. Treatment dilemmas in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2017;88(4):346-52.
Verboon C, van Berghem H, van Doorn PA, Ruts L, Jacobs BC. Prediction of disease progression in Miller Fisher and overlap syndromes. J Peripher Nerv Syst. 2017;22(4):446-50.
van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, et al. Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. Ann Neurol. 2017;81(2):193-8.
van Nierop GP, van Luijn MM, Michels SS, Melief MJ, Janssen M, Langerak AW, et al. Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. Acta Neuropathol. 2017;134(3):383-401.
Van Dongen JJM, Van der Velden VHJ, Brüggemann M, Orfao A. Minimal residual disease (MRD) diagnostics: Methodology and prognostic significance. In: Vora J, editor. Childhood acute lymphoblastic leukemia: Springer; 2017. p. 139-62.
van der Velden VH, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017.
van der Houwen TB, van Hagen PM, Timmermans WM, Bartol SJ, Lam KH, Kappen JH, et al. Chronic signs of memory B cell activation in patients with Behcet’s disease are partially restored by anti-tumour necrosis factor treatment. Rheumatology (Oxford). 2017;56(1):134-44.
van der Heiden M, Berbers GAM, Fuentes S, van Zelm MC, Boots AMH, Buisman AM. An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults. Front Immunol. 2017;8:1962.
van der Heiden M, Berbers GAM, Fuentes S, van Zelm MC, Boots AMH, Buisman AM. An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults. Front Immunol. 2017;8(JAN):1962.
van den Heuvel D, Jansen MAE, Nasserinejad K, Dik WA, van Lochem EG, Bakker-Jonges LE, et al. Effects of nongenetic factors on immune cell dynamics in early childhood: The Generation R Study. J Allergy Clin Immunol. 2017;139(6):1923-34 e17.
van den Heuvel D, Jansen MA, Bell AI, Rickinson AB, Jaddoe VW, van Dongen JJ, et al. Transient reduction in IgA(+) and IgG(+) memory B cell numbers in young EBV-seropositive children: the Generation R Study. J Leukoc Biol. 2017;101(4):949-56.
van den Bosch TP, Caliskan K, Kraaij MD, Constantinescu AA, Manintveld OC, Leenen PJ, et al. CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection. Front Immunol. 2017;8(MAR):346.
van den Boogaard ML, Thijssen PE, Aytekin C, Licciardi F, Kiykim AA, Spossito L, et al. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2. Clin Genet. 2017;92(4):380-7.
van Bezooijen JS, van Doorn MBA, Schreurs MWJ, Koch BCP, Te Velthuis H, Prens EP, et al. Prolongation of Biologic Dosing Intervals in Patients With Stable Psoriasis: A Feasibility Study. Ther Drug Monit. 2017;39(4):379-86.
van Bezooijen JS, Schreurs MWJ, Koch BCP, Velthuis HT, van Doorn MBA, Prens EP, et al. Intrapatient Variability in the Pharmacokinetics of Etanercept Maintenance Treatment. Ther Drug Monit. 2017;39(4):333-8.
van Beek AA, Hugenholtz F, Meijer B, Sovran B, Perdijk O, Vermeij WP, et al. Frontline Science: Tryptophan restriction arrests B cell development and enhances microbial diversity in WT and prematurely aging Ercc1(-/Delta7) mice. J Leukoc Biol. 2017;101(4):811-21.
Theunissen PMJ, van Zessen D, Stubbs AP, Faham M, Zwaan CM, van Dongen JJM, et al. Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones. Haematologica. 2017;102(11):1869-77.
Theunissen PMJ, van den Branden A, Van Der Sluijs-Gelling A, De Haas V, Beishuizen A, van Dongen JJM, et al. Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia. Br J Haematol. 2017;178(2):267-78.
Theunissen PMJ, Sedek L, De Haas V, Szczepanski T, Van Der Sluijs A, Mejstrikova E, et al. Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection. Br J Haematol. 2017;178(2):257-66.
Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347-57.
Tan ACS, Yzer S, Atebara N, Marr BP, Verdijk RM, Dalm V, et al. Three Cases of Erdheim-Chester Disease With Intraocular Manifestations: Imaging and Histopathology Findings of a Rare Entity. Am J Ophthalmol. 2017;176:141-7.
Sutton LA, Hadzidimitriou A, Baliakas P, Agathangelidis A, Langerak AW, Stilgenbauer S, et al. Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification. Haematologica. 2017;102(6):968-71.
Suez D, Krivan G, Jolles SR, Hussain I, Stein MR, Gupta S, et al. A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in Europe and North America. J Allergy Clin Immunol. 2017;139(2):AB216.
Stoop MP, Runia TF, Stingl C, van der Vuurst de Vries RM, Luider TM, Hintzen RQ. Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis. Proteomics Clin Appl. 2017;11(11-12).
Snijders G, Mesman E, de Wit H, Wijkhuijs A, Nolen WA, Drexhage HA, et al. Immune dysregulation in offspring of a bipolar parent. Altered serum levels of immune growth factors at adolescent age. Brain Behav Immun. 2017;64:116-23.
Snijders G, de Witte L, Mesman E, Kemner S, Vonk R, Brouwer R, et al. The seroprevalence of antithyroid peroxidase antibodies in bipolar families and bipolar twins: results from two longitudinal studies. Int J Bipolar Disord. 2017;5(1):1.
Singh SP, Rip J, Hendriks RW. Targeting Bruton’s tyrosine kinase expression levels through microRNAs in chronic lymphocytic leukemia treatment. Translational Cancer Research. 2017:S502-S7.
Singh SP, Pillai SY, de Bruijn MJW, Stadhouders R, Corneth OBJ, van den Ham HJ, et al. Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling. Oncotarget. 2017;8(42):71981-95.
Schauwvlieghe A, Vonk AG, Buddingh EP, Hoek RAS, Dalm VA, Klaassen CHW, et al. Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis. J Antimicrob Chemother. 2017;72(11):3047-50.
Rovito R, Korndewal MJ, van Zelm MC, Ziagkos D, Wessels E, van der Burg M, et al. T and B Cell Markers in Dried Blood Spots of Neonates with Congenital Cytomegalovirus Infection: B Cell Numbers at Birth Are Associated with Long-Term Outcomes. J Immunol. 2017;198(1):102-9.
Rosenquist R, Ghia P, Hadzidimitriou A, Sutton LA, Agathangelidis A, Baliakas P, et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations. Leukemia. 2017;31(7):1477-81.
Roodbol J, de Wit MY, van den Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, et al. Diagnosis of Guillain-Barre syndrome in children and validation of the Brighton criteria. J Neurol. 2017;264(5):856-61.
Razawy W, Alves CH, Molendijk M, Asmawidjaja PS, Mus AMC, Lubberts E. Experimental Arthritis Mouse Models Driven by Adaptive and/or Innate Inflammation. Methods Mol Biol. 2017;1559:391-410.
Rao VK, Webster S, Dalm V, Sediva A, van Hagen PM, Holland S, et al. Effective “activated PI3Kdelta syndrome”-targeted therapy with the PI3Kdelta inhibitor leniolisib. Blood. 2017;130(21):2307-16.
Poletti S, de Wit H, Mazza E, Wijkhuijs AJM, Locatelli C, Aggio V, et al. Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls. Brain Behav Immun. 2017;61:317-25.
Poletti S, Aggio V, Hoogenboezem TA, Ambree O, de Wit H, Wijkhuijs AJ, et al. Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder. Eur Psychiatry. 2017;40:33-7.
Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: Infection beyond the liver? J Hepatol. 2017;66(5):1082-95.
Paiva B, Puig N, Cedena MT, de Jong BG, Ruiz Y, Rapado I, et al. Differentiation stage of myeloma plasma cells: biological and clinical significance. Leukemia. 2017;31(2):382-92.
Paerewijck O, Maertens B, Dreesen L, Van Meulder F, Peelaers I, Ratman D, et al. Interleukin-17 receptor A (IL-17RA) as a central regulator of the protective immune response against Giardia. Sci Rep. 2017;7(1):8520.
Ozcan B, Leenen PJM, Delhanty PJD, Baldeon-Rojas LY, Neggers SJ, van der Lely AJ. Unacylated ghrelin modulates circulating angiogenic cell number in insulin-resistant states. Diabetol Metab Syndr. 2017;9(1):43.
Novakova M, Glier H, Brdickova N, Vlkova M, Santos AH, Lima M, et al. How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers. J Immunol Methods. 2017.
Nelde A, Walz JS, Kowalewski DJ, Schuster H, Wolz OO, Peper JK, et al. HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy. Oncoimmunology. 2017;6(3):e1219825.
Mourik BC, Lubberts E, de Steenwinkel JEM, Ottenhoff THM, Leenen PJM. Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Front Immunol. 2017;8(APR):294.
Mourik BC, Leenen PJ, de Knegt GJ, Huizinga R, van der Eerden BC, Wang J, et al. Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis. Am J Respir Cell Mol Biol. 2017;56(2):233-41.
Moser SC, Voerman JSA, Buckley DL, Winter GE, Schliehe C. Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules. Front Immunol. 2017;8:1920.
Moser SC, Voerman JSA, Buckley DL, Winter GE, Schliehe C. Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules. Front Immunol. 2017;8:1920.
Meijers RW, Dzierzanowska-Fangrat K, Zborowska M, Solarska I, Tielemans D, van Turnhout BA, et al. Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence. J Clin Immunol. 2017;37(2):133-42.
Meesilpavikkai K, Dik WA, Schrijver B, Nagtzaam NM, van Rijswijk A, Driessen GJ, et al. A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine Regulation. Front Immunol. 2017;8(MAR):274.
Matarraz S, Almeida J, Flores-Montero J, Lecrevisse Q, Guerri V, Lopez A, et al. Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry. Cytometry B Clin Cytom. 2017;92(3):218-27.
Martin-Martin L, Langerak AW, Quijano S, Almeida J, Flores-Montero J, Penalver J, et al. Occult CNS involvement by flow cytometry in aggressive lymphoma. . In: Van Dongen JJM, editor. 6th ESLHO symposium book. Leiden2017. p. 107-11.
Maria NI, Steenwijk EC, AS IJ, van Helden-Meeuwsen CG, Vogelsang P, Beumer W, et al. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2017;76(4):721-30.
Lukas D, Yogev N, Kel JM, Regen T, Mufazalov IA, Tang Y, et al. TGF-beta inhibitor Smad7 regulates dendritic cell-induced autoimmunity. Proc Natl Acad Sci U S A. 2017;114(8):E1480-E9.
Looman KIM, Jansen MAE, Voortman T, van den Heuvel D, Jaddoe VWV, Franco OH, et al. The role of vitamin D on circulating memory T cells in children: The Generation R study. Pediatr Allergy Immunol. 2017;28(6):579-87.
Langerak AW, van der Velden VHJ. Molecular diagnostics of lymphoid malignancies.  Molecular Diagnostics: Part 2: Clinical, Veterinary, Agrobotanical and Food Safety Applications2017. p. 103-29.
Langerak AW, Van der Velden VHJ. Molecular diagnostics of lymphoid malignancies. . In: Van Pelt-Verkuil E, van Leeuwen WB, Te Witt R, editors. Molecular diagnostics. Singapore: Springer; 2017. p. 103-29.
Langerak AW, Bruggemann M, Davi F, Darzentas N, van Dongen JJM, Gonzalez D, et al. High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges. J Immunol. 2017;198(10):3765-74.
Kuitwaard K, Fokkink WR, Brusse E, Vrancken A, Eftimov F, Notermans NC, et al. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2017;22(4):425-32.
Kuitwaard K, Fokkink WR, Brusse E, Vrancken A, Eftimov F, Notermans NC, et al. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2017;22(4):425-32.
Kotrova M, van der Velden VHJ, van Dongen JJM, Formankova R, Sedlacek P, Bruggemann M, et al. Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL. Bone Marrow Transplant. 2017;52(7):962-8.
Kosack L, Gawish R, Lercher A, Vilagos B, Hladik A, Lakovits K, et al. The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis. Sci Rep. 2017;7(1):11289.
Kleijn A, van den Bossche W, Haefner ES, Belcaid Z, Burghoorn-Maas C, Kloezeman JJ, et al. The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8(+)T Cell Anti-tumor Activity. Mol Ther Oncolytics. 2017;5:11-9.
Karim F, de Hoog J, Paridaens D, Verdijk R, Schreurs M, Rothova A, et al. IgG4-related disease as an emerging cause of scleritis. Acta Ophthalmol. 2017;95(8):e795-e6.
Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med. 2017;376(6):599-600.
Kannegieter NM, Hesselink DA, Dieterich M, Kraaijeveld R, Rowshani AT, Leenen PJ, et al. The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function. PLoS One. 2017;12(1):e0170806.
Kannegieter NM, Hesselink DA, Dieterich M, de Graav GN, Kraaijeveld R, Rowshani AT, et al. Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation. Ther Drug Monit. 2017;39(5):463-71.
Kalteren WS, Schreurs MWJ, Jorritsma-Smit A, Touw DJ, de Jong JW, Zweers P, et al. Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report. Br J Clin Pharmacol. 2017;83(10):2330-2.
Kallemeijn MJ, de Ridder D, Schilperoord-Vermeulen J, van der Klift MY, Sandberg Y, van Dongen JJ, et al. Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRgammadelta+ T cell large granular lymphocyte leukemia. PLoS One. 2017;12(4):e0175670.
Kallemeijn MJ, Boots AMH, van der Klift MY, Brouwer E, Abdulahad WH, Verhaar JAN, et al. Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells. Sci Rep. 2017;7(1):5509.
Kahlmann V, Roodbol J, van Leeuwen N, Ramakers CRB, van Pelt D, Neuteboom RF, et al. Validated age-specific reference values for CSF total protein levels in children. Eur J Paediatr Neurol. 2017;21(4):654-60.
Jansen MAE, van den Heuvel D, Jaddoe VWV, van Zelm MC, Moll HA. Abnormalities in CD57+ cytotoxic T cells and Vdelta1+ gammadeltaT cells in subclinical celiac disease in childhood are affected by cytomegalovirus. The Generation R Study. Clin Immunol. 2017;183:233-9.
Jansen MAE, van den Heuvel D, Jaddoe VWV, Moll HA, van Zelm MC. No Interactive Effects of Sex and Persistent Cytomegalovirus on Immune Phenotypes in Young Children: The Generation R Study. J Infect Dis. 2017;215(6):883-8.
Jansen MAE, Beth SA, van den Heuvel D, Kiefte-de Jong JC, Raat H, Jaddoe VWV, et al. Ethnic differences in coeliac disease autoimmunity in childhood: the Generation R Study. Arch Dis Child. 2017;102(6):529-34.
Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, et al. International Guillain-Barre Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome. J Peripher Nerv Syst. 2017;22(2):68-76.
Islam MB, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, et al. Small volume plasma exchange for Guillain-Barre syndrome in resource poor settings: a safety and feasibility study. Pilot Feasibility Stud. 2017;3:40.
Ishaque T, Islam MB, Ara G, Endtz HP, Mohammad QD, Jacobs BC, et al. High mortality from Guillain-Barre syndrome in Bangladesh. J Peripher Nerv Syst. 2017;22(2):121-6.
IJspeert H, van Schouwenburg PA, van Zessen D, Pico-Knijnenburg I, Stubbs AP, van der Burg M. Antigen Receptor Galaxy: A User-Friendly, Web-Based Tool for Analysis and Visualization of T and B Cell Receptor Repertoire Data. J Immunol. 2017;198(10):4156-65.
Huang L, Betjes MGH, Klepper M, Langerak AW, Baan CC, Litjens NHR. End-Stage Renal Disease Causes Skewing in the TCR Vbeta-Repertoire Primarily within CD8(+) T Cell Subsets. Front Immunol. 2017;8(DEC):1826.
Hope JL, Stairiker CJ, Spantidea PI, Gracias DT, Carey AJ, Fike AJ, et al. The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8(+) T Cells via SHIP-1. Front Immunol. 2017;8(DEC):1696.
Hofste op Bruinik D, Van der Velden VHJ. Minimale restziekte. In: Van de Donk NWCJ, Kramer PA, editors. Multipel myeloom: Academic Pharmaceutical Productions; 2017.
Hara M, Arino H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, et al. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology. 2017;88(14):1340-8.
Hanalioglu D, Ayvaz DC, Ozgur TT, van der Burg M, Sanal O, Tezcan I. A novel mutation in TAP1 gene leading to MHC class I deficiency: Report of two cases and review of the literature. Clin Immunol. 2017;178:74-8.
Haarman BCM, Burger H, Doorduin J, Renken RJ, Sibeijn-Kuiper AJ, Marsman JC, et al. Corrigendum to “Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study” [Brain Behav. Immun. (2015)]. Brain Behav Immun. 2017;61:387-8.
Gudmundsdottir J, Lundqvist C, Ijspeert H, van der Slik E, Oskarsdottir S, Lindgren S, et al. T-cell receptor sequencing reveals decreased diversity 18 years after early thymectomy. J Allergy Clin Immunol. 2017;140(6):1743-6 e7.
Groen-Hakan F, Eurelings L, ten Berge JC, van Laar J, Ramakers CRB, Dik WA, et al. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis. JAMA Ophthalmol. 2017;135(12):1352-8.
Groen F, van Laar JAM, Rothova A. Chest Radiographic Screening for Sarcoidosis in the Diagnosis of Patients with Active Uveitis. Ann Am Thorac Soc. 2017;14(6):912-8.
Ghanbari M, Iglesias AI, Springelkamp H, van Duijn CM, Ikram MA, Dehghan A, et al. A Genome-Wide Scan for MicroRNA-Related Genetic Variants Associated With Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2017;58(12):5368-77.
Ghanbari M, Erkeland SJ, Xu L, Colijn JM, Franco OH, Dehghan A, et al. Genetic variants in microRNAs and their binding sites within gene 3’UTRs associate with susceptibility to age-related macular degeneration. Hum Mutat. 2017;38(7):827-38.
Fokkink WR, Walgaard C, Kuitwaard K, Tio-Gillen AP, van Doorn PA, Jacobs BC. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barre Syndrome. JAMA Neurol. 2017;74(2):189-96.
Fokkink WR, Jacobs BC. Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barre Syndrome?-Reply. JAMA Neurol. 2017;74(7):872.
Fokkink W, Koch B, Ramakers C, van Doorn PA, van Gelder T, Jacobs BC. Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated Neuropathies. Clin Pharmacol Ther. 2017;102(4):709-16.
Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, Garcia-Sanchez O, Bottcher S, et al. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31(10):2094-103.
Fischer K, Al-Sawaf O, Fink AM, Dixon M, Bahlo J, Warburton S, et al. Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood. 2017;129(19):2702-5.
Eppinga H, Thio HB, Schreurs MWJ, Blakaj B, Tahitu RI, Konstantinov SR, et al. Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF). PLoS One. 2017;12(5):e0176955.
Eindhoven S, Levels J, Huisman M, de Winter KR, Dalm V, Alwani R. MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination. Allergy Asthma Clin Immunol. 2017;13(1):49.
Drenthen J, Roodbol J, Maathuis EM, Catsman-Berrevoets CE, Blok JH, de Wit MY, et al. Motor nerve excitability after childhood Guillain-Barre syndrome. J Peripher Nerv Syst. 2017;22(2):100-5.
Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, et al. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn. 2017;36(4):984-1008.
Dedeoglu B, de Weerd AE, Huang L, Langerak AW, Dor FJ, Klepper M, et al. Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation. Clin Exp Immunol. 2017;188(2):299-310.
de Jong BG, H IJ, Marques L, van der Burg M, van Dongen JJ, Loos BG, et al. Human IgG2- and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age. Immunol Cell Biol. 2017;95(9):744-52.
de Bruijn MJ, Rip J, van der Ploeg EK, van Greuningen LW, Ta VT, Kil LP, et al. Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling. J Immunol. 2017;198(8):3058-68.
Dalton HR, van Eijk JJJ, Cintas P, Madden RG, Jones C, Webb GW, et al. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017;67(5):925-32.
Cremers EM, Westers TM, Alhan C, Cali C, Visser-Wisselaar HA, Chitu DA, et al. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes. Haematologica. 2017;102(2):320-6.
Corneth OBJ, Verstappen GMP, Paulissen SMJ, de Bruijn MJW, Rip J, Lukkes M, et al. Enhanced Bruton’s Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease. Arthritis Rheumatol. 2017;69(6):1313-24.
Carey AJ, Hope JL, Mueller YM, Fike AJ, Kumova OK, van Zessen DBH, et al. Public Clonotypes and Convergent Recombination Characterize the Naive CD8(+) T-Cell Receptor Repertoire of Extremely Preterm Neonates. Front Immunol. 2017;8:1859.
Cante-Barrett K, Mendes RD, Li Y, Vroegindeweij E, Pike-Overzet K, Wabeke T, et al. Loss of CD44(dim) Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8(JAN):32.
Cagdas D, Aytac S, Kuskonmaz B, Ariga T, van der Burg M, Cetinkaya DU, et al. Low T Cell Numbers Resembling T-B+ SCID in a Patient with Wiskott-Aldrich Syndrome and the Outcome of Two Hematopoietic Stem Cell Transplantations. J Clin Immunol. 2017;37(1):18-21.
Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, et al. ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data. Bioinformatics. 2017;33(3):435-7.
Bruinsma IB, van Dijk M, Bridel C, van de Lisdonk T, Haverkort SQ, Runia TF, et al. Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS. J Neuroinflammation. 2017;14(1):235.
Bottcher S, van der Velden VHJ, Villamor N, Ritgen M, Flores-Montero J, Murua Escobar H, et al. Lot-to-lot stability of antibody reagents for flow cytometry. J Immunol Methods. 2017.
Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjogren’s syndrome: beyond the dryness – From pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;14(3):191-200.
Both T. Beyond the dryness of Sjögren’s syndrome : renal complications and bone metabolism [Ph.D. thesis]. Rotterdam: Erasmus University Rotterdam; 2017.
Boer JM, Steeghs EM, Marchante JR, Boeree A, Beaudoin JJ, Beverloo HB, et al. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia. Oncotarget. 2017;8(3):4618-28.
Blom M, Pico-Knijnenburg I, Sijne-van Veen M, Boelen A, Bredius RGM, van der Burg M, et al. An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program. Clin Immunol. 2017;180:106-10.
Blanco E, Perez-Andres M, Sanoja-Flores L, Wentink M, Pelak O, Martin-Ayuso M, et al. Selection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells. J Immunol Methods. 2017.
Bharwani KD, Dirckx M, Stronks DL, Dik WA, Schreurs MWJ, Huygen F. Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes? Mediators Inflamm. 2017;2017:2764261.
Berciano J, Sedano MJ, Pelayo-Negro AL, Garcia A, Orizaola P, Gallardo E, et al. Proximal nerve lesions in early Guillain-Barre syndrome: implications for pathogenesis and disease classification. J Neurol. 2017;264(2):221-36.
Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, et al. Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder. J Clin Psychiatry. 2017;78(8):e986-e93.
Bain CC, Montgomery J, Scott CL, Kel JM, Girard-Madoux MJH, Martens L, et al. TGFbetaR signalling controls CD103(+)CD11b(+) dendritic cell development in the intestine. Nat Commun. 2017;8(1):620.
Artlett CM, Sassi-Gaha S, Hope JL, Feghali-Bostwick CA, Katsikis PD. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther. 2017;19(1):144.
Alvarez-Twose I, Matito A, Morgado JM, Sanchez-Munoz L, Jara-Acevedo M, Garcia-Montero A, et al. Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature. Oncotarget. 2017;8(40):68950-63.
Allaerts W, Chang TW. Skewed Exposure to Environmental Antigens Complements Hygiene Hypothesis in Explaining the Rise of Allergy. Acta Biotheor. 2017;65(2):117-34.
PUBLICATIONS 2016
Zondag TC, Rokx C, van Lom K, van den Berg AR, Sonneveld P, Dik WA, et al. Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman’s disease complicated by hemophagocytic lymphohistiocytosis. Int J Hematol. 2016;103(4):469-72.
Wojtowicz EE, Lechman ER, Hermans KG, Schoof EM, Wienholds E, Isserlin R, et al. Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors. Cell Stem Cell. 2016;19(3):383-96.
Wohn C, Brand A, van Ettinger K, Brouwers-Haspels I, Waisman A, Laman JD, et al. Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A. Cell Immunol. 2016;308:57-65.
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016;388(10045):717-27.
Wiekmeijer AS, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero IL, Lankester AC, et al. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. J Allergy Clin Immunol. 2016;137(2):517-26 e3.
Virakul S, Phetsuksiri T, van Holten-Neelen C, Schrijver B, van Steensel L, Dalm VA, et al. Histamine induces NF-kappaB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1. Exp Eye Res. 2016;147:85-93.
Virakul S, Heutz JW, Dalm VA, Peeters RP, Paridaens D, van den Bosch WA, et al. Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts. Mol Cell Endocrinol. 2016;433:94-104.
Virakul S. New insights in the pathogenesis of Graves’ ophthalmopathy: potentials for targeted therapy [Ph.D. thesis]. Erasmus University Rotterdam: Erasmus University Rotterdam; 2016.
Veltman M, Stolarczyk M, Radzioch D, Wojewodka G, De Sanctis JB, Dik WA, et al. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931. Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L1000-L14.
Veen C, Myint AM, Burgerhout KM, Schwarz MJ, Schutze G, Kushner SA, et al. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression. J Affect Disord. 2016;189:298-305.
van Veen M, Nijman RG, Zijlstra M, Dik WA, de Rijke YB, Moll HA, et al. Neutrophil CD64 expression is not a useful biomarker for detecting serious bacterial infections in febrile children at the emergency department. Infect Dis (Lond). 2016;48(5):331-7.
van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87(14):1449-56.
van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time. Autoimmun Rev. 2016;15(10):970-4.
van Sonderen A, Schreurs MW, de Bruijn MA, Sillevis Smitt PA, Titulaer MJ. Antistofgeassocieerde encephalitis: handvatten voor diagnostiek en behandeling. Ned Tijdschr Neurol Neurochir. 2016;117(2):78-88.
van Sonderen A, Schreurs MW, de Bruijn MA, Boukhrissi S, Nagtzaam MM, Hulsenboom ES, et al. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology. 2016;86(18):1692-9.
van Sonderen A, Arino H, Petit-Pedrol M, Leypoldt F, Kortvelyessy P, Wandinger KP, et al. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016;87(5):521-8.
van Onkelen RS, Gosselink MP, van Meurs M, Melief MJ, Schouten WR, Laman JD. Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol. 2016;20(9):619-25.
van Nierop GP, Janssen M, Mitterreiter JG, van de Vijver DA, de Swart RL, Haagmans BL, et al. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients. Eur J Immunol. 2016;46(2):347-53.
van Luijn MM, van Meurs M, Stoop MP, Verbraak E, Wierenga-Wolf AF, Melief MJ, et al. Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions. J Neuropathol Exp Neurol. 2016;75(1):86-98.
van Leeuwen N, Lingsma HF, Vanrolleghem AM, Sturkenboom MC, van Doorn PA, Steyerberg EW, et al. Hospital Admissions, Transfers and Costs of Guillain-Barre Syndrome. PLoS One. 2016;11(2):e0143837.
van Gent DC, IJspeert H, van der Burg M. Nonhomologous end-joining.  DNA Replication, Recombination, and Repair: Molecular Mechanisms and Pathology: Springer Japan; 2016. p. 341-62.
Van Dongen JJM, Teodosio C, Van den Bossche WBL, Berkowska M, Perez M, Almeida J, et al. Nieuwe ontwikkelingen in immuunmonitoring: flowcytometrische analyse van differentiatie-, maturatie-, en activatieprocessen. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 177-83.
van Dongen JJM, Langerak AW, Kroese FGM. Vorming en expressie van antigeenreceptoren op T- en B-lymfocyten. In: Rijkers GT, Kroese FGM, Kallenberg CGM, Derksen RHWM, editors. Leerboek immunologie. Houten: Bohn, Stafleu, van Loghum; 2016. p. 103-26.
van der Zee HH, Horvath B, Jemec GBE, Prens EP. The Association between Hidradenitis Suppurativa and Crohn’s Disease: in Search of the Missing Pathogenic Link. J Invest Dermatol. 2016;136(9):1747-8.
Van der Velden VHJ, Theunissen PMJ, Van Der Sluijs-Gelling A, De Haas V, Van Dongen JJM, Consortium nhE. Detectie van minimale restziekte in acute lymfatische leukemie. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 99-116.
van der Velden VH, de Launaij D, de Vries JF, de Haas V, Sonneveld E, Voerman JS, et al. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia. Br J Haematol. 2016;172(5):769-81.
van der Valk JP, Schreurs MW, El Bouch R, Arends NJ, de Jong NW. Mono-sensitisation to peanut component Ara h 6: a case series of five children and literature review. Eur J Pediatr. 2016;175(9):1227-34.
van der Heiden M, van Zelm MC, Bartol SJ, de Rond LG, Berbers GA, Boots AM, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892.
van der Eerden BC, Koek WN, Roschger P, Zillikens MC, Waarsing JH, van der Kemp A, et al. Lifelong challenge of calcium homeostasis in male mice lacking TRPV5 leads to changes in bone and calcium metabolism. Oncotarget. 2016;7(18):24928-41.
Van der Burg M, IJspeert H, Driessen GJA. T-cel deficiënties. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 87-94.
van den Hoogen LL, Fritsch-Stork RD, Versnel MA, Derksen RH, van Roon JA, Radstake TR. Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use. Ann Rheum Dis. 2016;75(12):e81.
van den Heuvel D, Jansen MA, Dik WA, Bouallouch-Charif H, Zhao D, van Kester KA, et al. Cytomegalovirus- and Epstein-Barr Virus-Induced T-Cell Expansions in Young Children Do Not Impair Naive T-cell Populations or Vaccination Responses: The Generation R Study. J Infect Dis. 2016;213(2):233-42.
van den Berg R, Laman JD, van Meurs M, Hintzen RQ, Hoogenraad CC. Rotarod motor performance and advanced spinal cord lesion image analysis refine assessment of neurodegeneration in experimental autoimmune encephalomyelitis. J Neurosci Methods. 2016;262:66-76.
Van Den Berg B, Van Den Beukel JC, Alsma J, Van DenEijk AA, Ruts L, Van Doorn PA, et al. Guillain-Barré syndrome following infection with the Zika virus Background. Ned Tijdschr Geneeskd. 2016;160(21):D155.
Van Daele PLA. Immunosuppressive medication and infections. Nederlands Tijdschrift voor Dermatologie en Venereologie. 2016;26(9):525-7.
van Daele PL. Pamidronate in complex regional pain syndrome: effective therapy in CRPS. Neth J Med. 2016;74(1):3-4.
van Coevorden-Hameete MH, Titulaer MJ, Schreurs MW, de Graaff E, Sillevis Smitt PA, Hoogenraad CC. Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System. Front Mol Neurosci. 2016;9:37.
van Bezooijen JS, Koch BC, van Doorn MB, Prens EP, van Gelder T, Schreurs MW. Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations. Ther Drug Monit. 2016;38(4):432-8.
van Bezooijen JS, Balak DM, van Doorn MB, Looman CW, Schreurs MW, Koch BC, et al. Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study. Dermatology. 2016;232(4):407-14.
van Beek AA, Sovran B, Hugenholtz F, Meijer B, Hoogerland JA, Mihailova V, et al. Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1-/Delta7 Mice. Front Immunol. 2016;7:408.
Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, et al. Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response. Benef Microbes. 2016;7(2):275-87.
Timmermans WM, van Laar JA, van Hagen PM, van Zelm MC. Immunopathogenesis of granulomas in chronic autoinflammatory diseases. Clin Transl Immunology. 2016;5(12):e118.
Timmermans WM, van Laar JA, van der Houwen TB, Kamphuis LS, Bartol SJ, Lam KH, et al. B-Cell Dysregulation in Crohn’s Disease Is Partially Restored with Infliximab Therapy. PLoS One. 2016;11(7):e0160103.
Theunissen P, Mejstrikova E, Sedek L, Van der Sluijs A, Gaipa G, Bartels M, et al. Standardized next-generation flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. In: Van Dongen JJM, editor. 5th ESLHO Symposium New Developments in the ESLHO Networks. Leiden2016. p. 37-43.
Theunissen P. Normale en maligne B-cellen in acute lymfoblatische leukemie [Ph.D. thesis]: Erasmus University Rotterdam; 2016.
Ten Berge JC, van Rosmalen J, Vermeer J, Hellstrom C, Lindskog C, Nilsson P, et al. Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy. PLoS One. 2016;11(12):e0167909.
ten Berge JC, van Daele PL, Rothova A. Rubella Virus-associated Anterior Uveitis in a Vaccinated Patient: A Case Report. Ocul Immunol Inflamm. 2016;24(1):113-4.
Ten Berge JC, Schreurs MW, Vermeer J, Meester-Smoor MA, Rothova A. Prevalence and clinical impact of antiretinal antibodies in uveitis. Acta Ophthalmol. 2016;94(3):282-8.
Te Velde AA, Bezema T, van Kampen AH, Kraneveld AD, t Hart BA, van Middendorp H, et al. Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders. Front Immunol. 2016;7:587.
Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K, et al. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica. 2016;101(8):959-67.
Suratannon N, Yeetong P, Srichomthong C, Amarinthnukrowh P, Chatchatee P, Sosothikul D, et al. Adaptive immune defects in a patient with leukocyte adhesion deficiency type III with a novel mutation in FERMT3. Pediatr Allergy Immunol. 2016;27(2):214-7.
Stetler-Stevenson M, Paiva B, Stoolman L, Lin P, Jorgensen JL, Orfao A, et al. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition. Cytometry B Clin Cytom. 2016;90(1):26-30.
Snijders G, Schiweck C, Mesman E, Grosse L, De Wit H, Nolen WA, et al. A dynamic course of T cell defects in individuals at risk for mood disorders. Brain Behav Immun. 2016;58:11-7.
Schreurs MWJ, Titulaer MJ. Diagnostiek van neuronale antistoffen bij auto-immuun encefalitis. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016. p. 39-53.
Sandberg Y, Langerak AW, Lam KH, Rijneveld AW, van Lom K. [Leukocytosis and skin lesions: consider malignancy; adult T-cell leukaemia/lymphoma]
Leukocytose en huidafwijkingen: denk aan maligniteit; adulte T-celleukemie/-lymfoom. Ned Tijdschr Geneeskd. 2016;160:A9866.
Sandberg Y, Dijkshoorn ML, Schoots IG. [A woman with subcutaneous nodules after buttock augmentation]
Een vrouw met subcutane noduli na bilvergroting. Ned Tijdschr Geneeskd. 2016;160(0):D443.
Rother MB, Schreurs MW, Kroek R, Bartol SJ, van Dongen JJ, van Zelm MC. The Human Thymus Is Enriched for Autoreactive B Cells. J Immunol. 2016;197(2):441-8.
Rother MB, Palstra RJ, Jhunjhunwala S, van Kester KA, van IJcken WF, Hendriks RW, et al. Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci. Nucleic Acids Res. 2016;44(1):175-86.
Rother MB, Jensen K, van der Burg M, van de Bovenkamp FS, Kroek R, van IWF, et al. Decreased IL7Ralpha and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin. Sci Rep. 2016;6:33924.
Rokx C, van Laar JA, Rijnders BJ. Suggested Relationship Between Hemophagocytic Lymphohistiocytosis and Bartonella henselae. Clin Infect Dis. 2016;63(3):427-8.
Rietveld MJ, Schreurs MW, Gerth van Wijk R, van Daele PL, Hermans MA. The Basophil Activation Test Is Not a Useful Screening Tool for Hymenoptera Venom-Related Anaphylaxis in Patients with Systemic Mastocytosis. Int Arch Allergy Immunol. 2016;169(2):125-9.
Preijers FW, van der Velden VH, Preijers T, Brooimans RA, Marijt E, Homburg C, et al. Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward. Cytometry B Clin Cytom. 2016;90(3):267-78.
Pojero F, Flores-Montero J, Sanoja L, Perez JJ, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90(1):91-100.
Pieters R, de Groot-Kruseman H, Van der Velden V, Fiocco M, van den Berg H, de Bont E, et al. Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group. J Clin Oncol. 2016;34(22):2591-601.
Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, et al. Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients. Blood. 2016;127(25):3165-74.
Novakova M, Zaliova M, Sukova M, Wlodarski M, Janda A, Fronkova E, et al. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. Haematologica. 2016;101(6):707-16.
Nazary M, Prens EP, Boer J. Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients. Br J Dermatol. 2016;174(3):639-41.
Navrkalova V, Young E, Baliakas P, Radova L, Sutton LA, Plevova K, et al. ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. Haematologica. 2016;101(9):e369-73.
Muggen AF, Singh SP, Hendriks RW, Langerak AW. Targeting Signaling Pathways in Chronic Lymphocytic Leukemia. Curr Cancer Drug Targets. 2016;16(8):669-88.
Miller IM, Ring HC, Prens EP, Rytgaard H, Mogensen UB, Ellervik C, et al. Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases. Dermatology. 2016;232(4):511-9.
Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, et al. Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: A case-control study. Ann Neurol. 2016;80(4):566-80.
McGuiness B, Gibney SM, Beumer W, Versnel MA, Sillaber I, Harkin A, et al. Exaggerated Increases in Microglia Proliferation, Brain Inflammatory Response and Sickness Behaviour upon Lipopolysaccharide Stimulation in Non-Obese Diabetic Mice. Neuroimmunomodulation. 2016;23(3):137-50.
Mayado A, Teodosio C, Garcia-Montero AC, Matito A, Rodriguez-Caballero A, Morgado JM, et al. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression. Leukemia. 2016;30(1):124-30.
Massolt ET, Effraimidis G, Korevaar TI, Wiersinga WM, Visser WE, Peeters RP, et al. Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease. PLoS One. 2016;11(4):e0153892.
Maria NI, van Helden-Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, Dalm VA, et al. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjogren’s Syndrome. Arthritis Rheumatol. 2016;68(7):1688-99.
Lubberts E, Kolls JK. Utility of Adenoviral Vectors in Animal Models of Human Disease III: Acquired Diseases.  Adenoviral Vectors for Gene Therapy: Second Edition2016. p. 675-96.
Ljungstrom V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood. 2016;127(8):1007-16.
Lilleker JB, Jones MS, Mohanraj R, Yeo T, Chai JY, Tan K, et al. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology. 2016;87(17):1848-9.
Langerak T, Yang H, Baptista M, Doornekamp L, Kerkman T, Codrington J, et al. Zika Virus Infection and Guillain-Barre Syndrome in Three Patients from Suriname. Front Neurol. 2016;7(DEC):233.
Langerak AW, Dik WA, Lu L, Heezen KC, Swagemakers SMA, Van der Velden VHJ, et al. Diagnostiek van intra-oculair lymfoom: gecombineerde rol voor flowcytometrie en proteomics. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 117-30.
Langerak AW. Toward Standardization of Clonality Testing in Veterinary Medicine. Vet Pathol. 2016;53(4):705-6.
Lagresle-Peyrou C, Luce S, Ouchani F, Soheili TS, Sadek H, Chouteau M, et al. X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene. J Allergy Clin Immunol. 2016;138(6):1681-9 e8.
Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016;14(1):18.
Karim AF, Verdijk RM, Guenoun J, van Hagen PM, van Laar JA. An inflammatory condition with different faces: immunoglobulin G4-related disease. Neth J Med. 2016;74(3):110-5.
Kamphuis LSJ. The Many Faces of Sarcoidosis. Novel insights into pathogenesis, diagnostics and therapy [Ph.D. thesis]: Erasmus University Rotterdam; 2016.
Kallenberg CGM, Drexhage HA. Auto-immuniteit. In: Rijkers GT, Kroese FGM, Kallenberg CGM, Derksen RHWM, editors. Leerboek immunologie. Houten: Bohn, Stafleu, van Loghum; 2016. p. 343-80.
Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, et al. Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study. J Pediatr Gastroenterol Nutr. 2016;63(4):423-30.
Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, et al. Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood. J Pediatr. 2016;170:126-34 e1-6.
Janda A, Schwarz K, van der Burg M, Vach W, Ijspeert H, Lorenz MR, et al. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome. Blood. 2016;127(18):2193-202.
Jagessar SA, Holtman IR, Hofman S, Morandi E, Heijmans N, Laman JD, et al. Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein. J Immunol. 2016;197(4):1074-88.
Islam MB, Islam Z, Farzana KS, Sarker SK, Endtz HP, Mohammad QD, et al. Guillain-Barre syndrome in Bangladesh: validation of Brighton criteria. J Peripher Nerv Syst. 2016;21(4):345-51.
IJspeert H, van Schouwenburg PA, van Zessen D, Pico-Knijnenburg I, Driessen GJ, Stubbs AP, et al. Evaluation of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and Adults. Front Immunol. 2016;7(OCT):410.
IJspeert H, Van Schouwenburg PA, Van der Burg M. Strategieën voor repertoire analyse. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 161-76.
IJspeert H, Rozmus J, Schwarz K, Warren RL, van Zessen D, Holt RA, et al. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood. 2016;128(5):650-9.
Huang L, Langerak AW, Baan CC, Litjens NH, Betjes MG. Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients. Clin Exp Immunol. 2016;186(2):239-48.
Hope JL, Pulendran B, Schoenberger SP, Katsikis PD. 1st International Conference on Human &Translational Immunology. Nat Immunol. 2016;18(1):1-4.
Hoorn EJ, Taams NE, Hurskainen T, Salih M, Weening JJ, Jonkman MF, et al. Bullous Pemphigoid With a Dual Pattern of Glomerular Immune Complex Disease. Am J Kidney Dis. 2016;67(2):302-6.
Hintzen RQ, Dale RC, Neuteboom RF, Mar S, Banwell B. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis. Neurology. 2016;87(9 Suppl 2):S67-73.
Heeringa JJ, van Zelm MC. Is there a pathogenic role for IgE in psoriasis? Br J Dermatol. 2016;175(1):16-7.
Heeringa JJ, Hajdarbegovic E, Thio HB, van Zelm MC. Systemic B-cell abnormalities in patients with atopic dermatitis? J Allergy Clin Immunol. 2016;138(1):317-8.
Halstead SK, Kalna G, Islam MB, Jahan I, Mohammad QD, Jacobs BC, et al. Microarray screening of Guillain-Barre syndrome sera for antibodies to glycolipid complexes. Neurol Neuroimmunol Neuroinflamm. 2016;3(6):e284.
Haarman BC, Riemersma-Van der Lek RF, Burger H, Drexhage HA, Nolen WA. The dysregulated brain: consequences of spatial and temporal brain complexity for bipolar disorder pathophysiology and diagnosis. Bipolar Disord. 2016;18(8):696-701.
Haarman BC, Riemersma-Van der Lek RF, Burger H, de Groot JC, Drexhage HA, Nolen WA, et al. Diffusion tensor imaging in euthymic bipolar disorder – A tract-based spatial statistics study. J Affect Disord. 2016;203:281-91.
Haarman BC, Burger H, Doorduin J, Renken RJ, Sibeijn-Kuiper AJ, Marsman JB, et al. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study. Brain Behav Immun. 2016;56:21-33.
Grosse L, Hoogenboezem T, Ambree O, Bellingrath S, Jorgens S, de Wit HJ, et al. Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation. Brain Behav Immun. 2016;54:38-44.
Grosse L, Carvalho LA, Birkenhager TK, Hoogendijk WJ, Kushner SA, Drexhage HA, et al. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology (Berl). 2016;233(9):1679-88.
Gracias DT, Boesteanu AC, Fraietta JA, Hope JL, Carey AJ, Mueller YM, et al. Phosphatidylinositol 3-Kinase p110delta Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections. J Immunol. 2016;196(3):1186-98.
Girard-Madoux MJ, Ober-Blobaum JL, Costes LM, Kel JM, Lindenbergh-Kortleve DJ, Brouwers-Haspels I, et al. IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine. Oncotarget. 2016;7(22):32015-30.
Ghanbari M, Ikram MA, de Looper HW, Hofman A, Erkeland SJ, Franco OH, et al. Genome-wide identification of microRNA-related variants associated with risk of Alzheimer’s disease. Sci Rep. 2016;6:28387.
Ghanbari M, Darweesh SK, de Looper HW, van Luijn MM, Hofman A, Ikram MA, et al. Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease. Hum Mutat. 2016;37(3):292-300.
Gervin K, Page CM, Aass HC, Jansen MA, Fjeldstad HE, Andreassen BK, et al. Cell type specific DNA methylation in cord blood: A 450K-reference data set and cell count-based validation of estimated cell type composition. Epigenetics. 2016;11(9):690-8.
Garcia-Montero AC, Jara-Acevedo M, Alvarez-Twose I, Teodosio C, Sanchez-Munoz L, Muniz C, et al. KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression. Blood. 2016;127(6):761-8.
Fokkink WJ, Haarman AE, Tio-Gillen AP, van Rijs W, Huizinga R, van Doorn PA, et al. Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS. Ann Clin Transl Neurol. 2016;3(7):547-51.
Flores-Montero J, de Tute R, Paiva B, Perez JJ, Bottcher S, Wind H, et al. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma. Cytometry B Clin Cytom. 2016;90(1):61-72.
Esenboga S, Ayvaz DC, Cetinkaya PG, van der Burg M, Tezcan I. An infant with ZAP-70 deficiency with disseminated mycobacterial disease. J Clin Immunol. 2016;36(2):103-6.
Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, et al. Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci. Pediatr Blood Cancer. 2016;63(10):1704-12.
Dunham J, Lee LF, van Driel N, Laman JD, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11(1):73-83.
Driessen GJ, IJspeert H, Wentink M, Yntema HG, van Hagen PM, van Strien A, et al. Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency. J Allergy Clin Immunol. 2016;138(6):1744-7 e5.
Drexhage HA, Dik WA, Leenen PJ, Versnel MA. The Immune Pathogenesis of Type 1 Diabetes: Not Only Thinking Outside the Cell but Also Outside the Islet and Out of the Box. Diabetes. 2016;65(8):2130-3.
Dik WA, Virakul S, van Steensel L. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves’ ophthalmopathy. Exp Eye Res. 2016;142:83-91.
Dik WA, Paridaens D, Dalm VASH, Peeters RP, Van Hagen PM. Graves’ orbitopathie: pathogenese en behandeling. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016. p. 11-28.
Denys B, Van der Velden V, Boeckx N. Hematologische maligniteiten – leukemie. In: Bossuyt X, editor. Wegwijs in laboratorium-diagnose. Leuven: Acco; 2016. p. 101-14.
Deckers IE, van der Zee HH, Prens EP. Severe fatigue based on anaemia in patients with hidradenitis suppurativa: report of two cases and a review of the literature. J Eur Acad Dermatol Venereol. 2016;30(1):174-5.
de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood. J Proteome Res. 2016;15(6):1853-61.
Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2016;7(JAN):697.
Damasceno D, Andres MP, van den Bossche WB, Flores-Montero J, de Bruin S, Teodosio C, et al. Expression profile of novel cell surface molecules on different subsets of human peripheral blood antigen-presenting cells. Clin Transl Immunology. 2016;5(9):e100.
Dalm VASH, Van der Burg M, Van Hagen PM. Humorale immuundeficiënties: kliniek en diagnostiek. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 57-73.
Chan MK, Cooper JD, Bot M, Birkenhager TK, Bergink V, Drexhage HA, et al. Blood-based immune-endocrine biomarkers of treatment response in depression. J Psychiatr Res. 2016;83:249-59.
Carey AJ, Gracias DT, Thayer JL, Boesteanu AC, Kumova OK, Mueller YM, et al. Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice. J Immunol. 2016;196(6):2602-13.
Cao Y, Jansen ID, Sprangers S, Stap J, Leenen PJ, Everts V, et al. IL-1beta differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets. J Leukoc Biol. 2016;100(3):513-23.
Cantaert T, Schickel JN, Bannock JM, Ng YS, Massad C, Delmotte FR, et al. Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint. J Clin Invest. 2016;126(11):4289-302.
Burgerhout K. Postpartum Psychosis : Treatment, follow-up and immunological parameters [Ph.D. thesis]: Erasmus University Rotterdam; 2016.
Brkic Z, van Bon L, Cossu M, van Helden-Meeuwsen CG, Vonk MC, Knaapen H, et al. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Ann Rheum Dis. 2016;75(8):1567-73.
Both T, Zillikens MC, Hoorn EJ, Zietse R, van Laar JA, Dalm VA, et al. Bone Mineral Density in Sjogren Syndrome Patients with and Without Distal Renal Tubular Acidosis. Calcif Tissue Int. 2016;98(6):573-9.
Beth SA, Jansen MA, Elfrink ME, Kiefte-de Jong JC, Wolvius EB, Jaddoe VW, et al. Generation R birth cohort study shows that specific enamel defects were not associated with elevated serum transglutaminase type 2 antibodies. Acta Paediatr. 2016;105(10):e485-91.
Berk KAC, Oudshoorn TP, Verhoeven AJM, Mulder MT, Roks AJM, Dik WA, et al. Effect van gewichtsverlies door het volgen van een dieet op markers van endotheel dysfunctioneren en inflammatie bij behandelde diabetes type 2 patiënten. Voeding & Visie. 2016;29:8-13.
Berk KA, Oudshoorn TP, Verhoeven AJM, Mulder MT, Roks AJM, Dik WA, et al. Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes. Clinical Nutrition ESPEN. 2016;15:101-6.
Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambree O, de Wit H, et al. Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder. J Affect Disord. 2016;202:1-9.
Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, Ambree O, de Wit H, et al. Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. J Neuroimmune Pharmacol. 2016;11(2):248-58.
Baldeon Rojas L, Weigelt K, de Wit H, Ozcan B, van Oudenaren A, Sempertegui F, et al. Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. Diabetol Metab Syndr. 2016;8:6.
Avellino R, Havermans M, Erpelinck C, Sanders MA, Hoogenboezem R, van de Werken HJ, et al. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation. Blood. 2016;127(24):2991-3003.
Alves CH, Farrell E, Vis M, Colin EM, Lubberts E. Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review. Clin Rev Allergy Immunol. 2016;51(1):27-47.
Alemdehy MF, De Looper HWJ, Kavelaars FG, Sanders MA, Hoogenboezem R, Löwenberg B, et al. MicroRNA-155 induces AML in combination with the loss of C/EBPA in mice. Leukemia. 2016;30(11):2238-41.
Akar HH, Patiroglu T, Hershfield M, van der Burg M. Combined immunodeficiencies: twenty years experience from a single center in Turkey. Cent Eur J Immunol. 2016;41(1):107-15.
Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016 September 2016. 186 p.
PUBLICATIONS 2015
Ambree O, Bergink V, Grosse L, Alferink J, Drexhage HA, Rothermundt M, et al. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression. Int J Neuropsychopharmacol. 2015;19(3):pyv103.
Close Menu